Kyongbo Pharmaceutical Co Ltd (214390) - Total Liabilities

Latest as of September 2025: ₩171.21 Billion KRW ≈ $116.03 Million USD

Based on the latest financial reports, Kyongbo Pharmaceutical Co Ltd (214390) has total liabilities worth ₩171.21 Billion KRW (≈ $116.03 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Kyongbo Pharmaceutical Co Ltd (214390) cash flow conversion to assess how effectively this company generates cash.

Kyongbo Pharmaceutical Co Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Kyongbo Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Kyongbo Pharmaceutical Co Ltd (214390) asset resilience to evaluate the company's liquid asset resilience ratio.

Kyongbo Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Kyongbo Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
MagnaChip Semiconductor NYSE:MX	USA	$104.26 Million
Mobile Infrastructure Corporation NYSE MKT:BEEP	USA	$228.10 Million
CanAlaska Uranium Ltd V:CVV	Canada	CA$7.08 Million
Shemen Industries Ltd TA:SMNIN	Israel	ILA88.93 Million
S&D Co. Ltd. KQ:260970	Korea	₩29.51 Billion
Brii Biosciences Limited F:7SS	Germany	€51.48 Million
Swelect Energy Systems Limited NSE:SWELECTES	India	Rs8.61 Billion
Kewaunee Scientific Corporation NASDAQ:KEQU	USA	$117.36 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Kyongbo Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Kyongbo Pharmaceutical Co Ltd (214390) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.18	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.54	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kyongbo Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kyongbo Pharmaceutical Co Ltd (2014–2024)

The table below shows the annual total liabilities of Kyongbo Pharmaceutical Co Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩137.73 Billion ≈ $93.34 Million	+12.97%
2023-12-31	₩121.92 Billion ≈ $82.63 Million	+25.90%
2022-12-31	₩96.84 Billion ≈ $65.63 Million	+6.09%
2021-12-31	₩91.28 Billion ≈ $61.86 Million	-6.08%
2020-12-31	₩97.18 Billion ≈ $65.86 Million	+9.62%
2019-12-31	₩88.65 Billion ≈ $60.08 Million	+22.09%
2018-12-31	₩72.61 Billion ≈ $49.21 Million	+14.60%
2017-12-31	₩63.36 Billion ≈ $42.94 Million	-14.76%
2016-12-31	₩74.33 Billion ≈ $50.37 Million	+2.29%
2015-12-31	₩72.67 Billion ≈ $49.25 Million	-27.11%
2014-12-31	₩99.70 Billion ≈ $67.57 Million	--

About Kyongbo Pharmaceutical Co Ltd

KO:214390 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$108.22 Million

₩159.70 Billion KRW

Market Cap Rank

#18883 Global

#992 in Korea

Share Price

₩6680.00

Change (1 day)

-1.76%

52-Week Range

₩4765.00 - ₩8550.00

All Time High

₩19100.23